The paradox of Epstein-Barr virus-associated hepatitis

Journal of Hepatology

Volumn 44, Issue 5, 2006, Pages 839-841

  Negro, Francesco ^a  

^a UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE; DISEASE TRANSMISSION; EDITORIAL; EPSTEIN BARR VIRUS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; LIVER FAILURE; LIVER INJURY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SALIVA; VIRUS HEPATITIS; VIRUS REPLICATION;

EPSTEIN-BARR VIRUS INFECTIONS; HEPATITIS, VIRAL, HUMAN; HUMANS;

EID: 33645781094     PISSN: 01688278     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jhep.2006.03.002     Document Type: Editorial

References (37)

1. Roizman B., and Baines J. The diversity and unity of Herpesviridae. Comp Immunol Microbiol Infect Dis 14 (1991) 63-79
2. Tugizov S.M., Berline J.W., and Palefsky J.M. Epstein-Barr virus infection or polarized tongue and nasopharyngeal epithelial cells. Nat Med 9 (2003) 307-314
3. Tsurumi T., Fujita M., and Kudoh A. Latent and lytic Epstein-Barr virus replication strategies. Rev Med Virol 15 (2005) 3-15
4. Klenerman P., and Hill A. T cells and viral persistence: lessons from diverse infections. Nat Immunol 6 (2005) 873-879
5. Parkin DM. The global health burden of infection-associated cancers in the year 2002. Int J Cancer, in press.
6. Hildesheim A., and Levine P.H. Etiology of nasopharyngeal carcinoma: a review. Epidemiol Rev 15 (1993) 466-485
7. McCarthy M., Ramage J., McNair A., Gane E., Portmann B., Pagliuca A., et al. The clinical diversity and role of chemotherapy in lymphoproliferative disorder in liver transplant recipients. J Hepatol 27 (1997) 1015-1021
8. White N.J., and Juel-Nelsen B.E. Infectious mononucleosis hepatitis. Semin Liver Dis 4 (1984) 301-306
9. Shaukat A., Tsai H.T., Rutherford R., and Anania F.A. Epstein-Barr virus induced hepatitis: an important cause of cholestasis. Hepatol Res 33 (2005) 24-26
10. Kimura H., Nagasaka T., Hoshino Y., Hayashi N., Tanaka N., Xu J.L., et al. Severe hepatitis caused by Epstein-Barr virus without infection of hepatocytes. Hum Pathol 32 (2001) 757-762
11. Hinedi T.B., and Koff R.S. Cholestatic hepatitis induced by Epstein-Barr virus infection in an adult. Dig Dis Sci 48 (2003) 539-541
12. Kikuchi K., Miyakawa H., Abe K., Fujikawa H., Horiuchi T., Nagai K., et al. Vanishing bile duct syndrome associated with chronic EBV infection. Dig Dis Sci 45 (2000) 160-165
13. Pelletier L.L., Borel D.M., Romig D.A., and Liu C. Disseminated intravascular coagulation and hepatic necrosis. Complications of infectious mononucleosis. J Am Med Assoc 235 (1976) 1144-1146
14. Markin R.S., Linder J., Zuerlein K., Mroczek E., Grierson H.L., Brichacek B., et al. Hepatitis in fatal infectious mononucleosis. Gastroenterology 93 (1987) 1210-1217
15. Jimenez-Saenz M., Perez-Pozo J.M., Leal-Luna A., and Herrerias-Gutierrez J.M. Lethal liver failure in an elderly patient with hepatitis B superinfected with Epstein-Barr virus. Eur J Gastroenterol Hepatol 14 (2002) 1283-1284
16. Cacopardo B., Nunnari G., Mughini M.T., Tosto S., Benanti F., and Nigro L. Fatal hepatitis during Epstein-Barr virus reactivation. Eur Rev Med Pharmacol Sci 7 (2003) 107-109
17. Chiba T., Goto S., Yokosuka O., Imazeki F., Tanaka M., Fukai K., et al. Fatal chronic active Epstein-Barr virus infection mimicking autoimmune hepatitis. Eur J Gastroenterol Hepatol 16 (2004) 225-228
18. Vento S., and Cainelli F. Is there a role for viruses in triggering autoimmune hepatitis?. Autoimmun Rev 3 (2004) 61-69
19. Biest S., and Schubert T.T. Chronic Epstein-Barr virus infection: a cause of granulomatous hepatitis?. J Clin Gastroenterol 11 (1989) 343-346
20. Sakamoto T., Uemura M., Fukui H., Yoshikawa M., Fukui K., Kinoshita K., et al. Chronic active Epstein-Barr virus infection in an adult. Intern Med 31 (1992) 1190-1196
21. Yuge A., Kinoshita E., Moriuchi M., Ohno Y., Haga H., and Moriuchi H. Persistent hepatitis associated with chronic active Epstein-Barr virus infection. Pediatr Infect Dis J 23 (2004) 74-76
22. Herrmann K., and Niedobitek G. Epstein-Barr virus-associated carcinomas: facts and fiction. J Pathol 199 (2003) 140-145
23. Si M.W., Thorson J.A., Lauwers G.Y., Dal Cin P., and Furman J. Hepatocellular lymphoepithelioma-like carcinoma associated with Epstein-Barr virus. Diagn Mol Pathol 13 (2004) 183-189
24. Jeng Y.M., Chen C.L., and Hsu H.C. Lymphoepithelioma-like cholangiocarcinoma. An Epstein-Barr virus-associated tumor. Am J Surg Pathol 25 (2001) 516-520
25. Tsuchiya S. Diagnosis of Epstein-Barr virus-associated diseases. Crit Rev Oncol Hematol 44 (2002) 227-238
26. Hara S., Hoshino Y., Naitou T., Nagano K., Iawi M., Suzuki K., et al. Association of virus infected-T cell in severe hepatitis caused by primary Epstein-Barr virus infection. J Clin Virol 35 (2006) 250-256
27. Bertolini L., Iacovacci S., Bosman C., Carloni G., Monaco V., Bangrazi C., et al. Low cell dosage of lymphoblastoid human cell line EBV+ is associated to chronic hepatitis in a minority of inoculated Nu/Nu mice. J Med Virol 66 (2002) 70-81
28. Timens W., Boes A., Vos H., and Poppema S. Tissue distribution of the C3d/EBV-receptor: CD21 monoclonal antibodies reactive with a variety of epithelial cells, medullary thymocytes, and peripheral T-cells. Histochemistry 95 (1991) 605-611
29. Sixbey J.W., Nedrud J.G., Raab-Traub N., Hanes R.A., and Pagano J.S. Epstein-Barr virus replication in oropharyngeal epithelial cells. N Engl J Med 310 (1984) 1225-1230
30. Jackson T., Sharma A., Ghazaleh R.A., Blakemore W.E., Ellard F.M., Simmons D.L., et al. Arginine-glycine-aspartic acid-specific binding by foot-and-mouth disease viruses to the purified integrin ανβ3 in vitro. J Virol 74 (2000) 4949-4956
31. Nemerow G.R. Cell receptors involved in adenovirus entry. Virology 274 (2000) 1-4
32. Drebber U., Kasper H.U., Krupacz J., Haferkamp K., Kern M.A., Steffen H.M., et al. The role of Epstein-Barr virus in acute and chronic hepatitis. J Hepatol 44 (2006) 879-885
33. Fan H., and Gulley M.L. Epstein-Barr viral load measurement as a marker of EBV-related disease. Mol Diagn 6 (2001) 279-289
34. Beuselinck K., van Ranst M., and van Eldere J. Automated extraction of viral-pathogen RNA and DNA for high-throughput quantitative real-time PCR. J Clin Microbiol 43 (2005) 5541-5546
35. Ruiz G., Pena P., de Ory F., and Echevarria J.E. Comparison of commercial real-time PCR assays for quantification of Epstein-Barr virus DNA. J Clin Microbiol 43 (2005) 2053-2057
36. Stevens S.J., Verkuijlen S.A., and Middeldorp J.M. Quantitative detection of Epstein-Barr virus DNA in clinical specimens by rapid real-time PCR targeting a highly conserved region of EBNA-1. Methods Mol Biol 292 (2005) 15-26
37. Ryan J.L., Fan H., Glaser S.L., Schichman S.A., Rab-Tarub N., and Gulley M.L. Epstein-Barr virus quantitation by real-time PCR targeting multiple gene segments: a novel approach to screen for the virus in paraffin-embedded tissue and plasma. J Mol Diagn 6 (2004) 378-385